Although metformin was introduced as a treatment for type 2 diabetes nearly 60 years ago and is now the recommended first-line treatment for newly diagnosed patients, researchers still debate precisely how the drug works. ...
(HealthDay)—For patients with type 2 diabetes, the lowest glucose variability (GV) and hypoglycemia is seen for patients using basal insulin + glucagon-like peptide 1 receptor agonist (GLP-1 RA) (BGLP), according to a study ...
(HealthDay)—Lower-income patients with diabetes and private insurance with a low (LD) or high deductible (HD) have reduced medical service use, according to a study published online Dec. 12 in Diabetes Care.
(HealthDay)—Time-updated hemoglobin A1c (HbA1c) variables have a stronger association with myocardial infarction (MI) than baseline HbA1c, according to a study published online May 26 in Diabetes Care.
(HealthDay)—Enrichment of gut microbiota with Lactobacillus reuteri is associated with increased insulin secretion, according to a study published in the October issue of Diabetes Care.
(HealthDay)—Nocturnal hypoglycemia is associated with reduced awakening response, according to a study published online Sept. 25 in Diabetes Care.
Strokes and heart attacks are rare for women with diabetes who use hormonal contraception, with the safest options being intrauterine devices (IUDs) and under-the-skin implants, new research published in Diabetes Care shows.
(HealthDay)—The order in which obese people with type 2 diabetes eat their food can affect their blood sugar levels, a small study suggests.
(HealthDay)—For hospitalized patients with diabetes, treatment with premixed insulin results in similar glycemic control but higher frequency of hypoglycemia compared with a basal-bolus regimen, according to a study published ...
(HealthDay)—The risk of developing diabetes is higher in younger adults versus middle-aged adults despite the same duration and degree of weight gain, according to research published online Sept. 10 in Diabetes Care.